RICE HALL JAMES & ASSOCIATES, LLC - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$497,307
-21.3%
91,249
-1.9%
0.03%
-11.1%
Q2 2023$631,619
+40.9%
93,022
+4.0%
0.04%
+44.0%
Q1 2023$448,295
+5.5%
89,480
+2.7%
0.02%
+4.2%
Q4 2022$424,999
-67.5%
87,090
-3.9%
0.02%
-68.4%
Q3 2022$1,307,000
-6.0%
90,665
-1.3%
0.08%
+13.4%
Q2 2022$1,390,000
+29.4%
91,898
+1.7%
0.07%
+55.8%
Q1 2022$1,074,000
-21.5%
90,375
+7.1%
0.04%
-12.2%
Q4 2021$1,368,000
-51.7%
84,395
-15.0%
0.05%
-53.3%
Q3 2021$2,834,000
-13.4%
99,291
+2.6%
0.10%
-9.5%
Q2 2021$3,271,000
+7.1%
96,774
-4.2%
0.12%
+16.0%
Q1 2021$3,055,000
-38.9%
101,028
+0.0%
0.10%
-43.2%
Q4 2020$5,000,000
+37.7%
100,994
+6.8%
0.18%
+20.5%
Q3 2020$3,630,000
+30.6%
94,567
+47.0%
0.15%
+22.7%
Q2 2020$2,779,000
+67.3%
64,326
+1.1%
0.12%
+28.0%
Q1 2020$1,661,000
+34.4%
63,628
+60.8%
0.09%
+121.4%
Q4 2019$1,236,00039,5660.04%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$2,271,0002.63%
Sofinnova Investments, Inc. 2,194,278$26,068,0001.98%
MPM BioImpact LLC 443,702$5,271,0001.42%
Soleus Capital Management, L.P. 238,982$2,839,0000.37%
Lombard Odier Asset Management (Switzerland) SA 221,774$2,635,0000.21%
Artal Group S.A. 400,000$4,752,0000.20%
Polar Capital Holdings Plc 2,877,671$34,187,0000.15%
ASHFORD CAPITAL MANAGEMENT INC 106,770$1,268,0000.14%
Cormorant Asset Management, LP 150,000$1,782,0000.14%
Virtus ETF Advisers LLC 23,646$281,0000.13%
View complete list of Y-MABS THERAPEUTICS INC shareholders